8-K current report · filed Oct 14, 2026

PULSE BIOSCIENCES, INC. (PLSE) 8-K Current Report: October 14, 2026

Item 8.01PLSE overview

Short answer

PULSE BIOSCIENCES, INC. (PLSE) filed an 8-K current report with the SEC on October 14, 2026 reporting Item 8.01 (Other Events). Commercial and clinical partnership with Clayman Thyroid Center and affiliates in Tampa, Florida.

PULSE BIOSCIENCES, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • Commercial and clinical partnership with Clayman Thyroid Center and affiliates in Tampa, Florida
  • Partnership will evaluate clinical utility of Pulse’s proprietary nPulse Vybrance Percutaneous Electrode System
  • Potential validation and adoption pathway for the company’s technology in thyroid procedures
  • No transaction value, revenue commitment, or commercialization timeline disclosed in the filing text

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other PULSE BIOSCIENCES, INC. 8-K filings

Get the next PLSE 8-K as it lands

Follow PLSE for push alerts, or ask the research agent what this filing means.